HALO logo
halo search icon
AnaptysBio, Inc.

US$60.41

Price Change Indicator
0.33 (0.549%)
AnaptysBio, Inc.
ANAB · NAS

AnaptysBio, Inc.

Start Trading ANAB for Free

US$60.41

Price Arrow0.33 (0.549%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleEngulfing BullishEngulfing Bullish (Realtime)HALO AllHALO Earnings MomentumHALO Momentum+2
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AnaptysBio, Inc. Overview

ANAB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Neutral

About ANAB

icon
icon

Telephone

1.858.362.6295

icon

Address

Suite 210, 10770 Wateridge Circle, San Diego, CA 92121-5801

Description

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.

ANAB Price Chart

Key Stats

Market Cap

US$1.75B

PE

0.00

EV/EBITDA

27

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 11.4 - 72.36

Trade Value (12mth)

US$4,196,140.00

1 week

-4.86%

1 month

12.19%

YTD

100.52%

1 year

334.59%

All time high

89.32

Key Fundamentals

EPS 3 yr Growth

-89.90%

EBITDA Margin

21.40%

Operating Cashflow

$20m

Free Cash Flow Return

5.20%

ROIC

-3.50%

Interest Coverage

0.60

Quick Ratio

9.10

Other Data

Shares Outstanding (Fully Diluted)

29m

HALO Sector

Healthcare

Next Company Report Date

09-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ANAB Announcements

Latest Announcements

DateAnnouncements
22 May 26
22 May 26
22 May 26
13 May 26
13 May 26

ANAB Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-6.08-5.12-0.46locklocklock
EPS (Fully Diluted)
 $locklocklocklock-6.08-5.12-0.46locklocklock
Growth
 %locklocklocklock-3315.891locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/A27locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of AnaptysBio, Inc. (ANAB:NAS)?
Halo FAQ
The current share price of AnaptysBio, Inc. (ANAB:NAS) is USD$60.41.
What is the 52-week high share price for AnaptysBio, Inc. (ANAB:NAS)?
Halo FAQ
The 52-week high share price for AnaptysBio, Inc. (ANAB:NAS) is USD$72.36.
What is the 52-week low share price for AnaptysBio, Inc. (ANAB:NAS)?
Halo FAQ
The 52-week low share price for AnaptysBio, Inc. (ANAB:NAS) is USD$11.40.
What is the dividend yield for AnaptysBio, Inc. (ANAB:NAS)?
Halo FAQ
AnaptysBio, Inc. (ANAB:NAS) does not pay a dividend.
What was AnaptysBio, Inc. (ANAB:NAS) last dividend payment?
Halo FAQ
AnaptysBio, Inc. (ANAB:NAS) does not pay a dividend.
What is the franking level for AnaptysBio, Inc. (ANAB:NAS)?
Halo FAQ
AnaptysBio, Inc. (ANAB:NAS) has a franking level of 0.00%.
In which sector is AnaptysBio, Inc. (ANAB:NAS) classified?
Halo FAQ
AnaptysBio, Inc. (ANAB:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial